Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 7/20 | 1.00 |
| ▸ | HTR2A | P28223 | 7/20 | 1.00 |
| ▸ | HTR1A | P08908 | 7/20 | 1.00 |
| ▸ | HTR1D | P28221 | 6/20 | 1.00 |
| ▸ | HTR1B | P28222 | 4/20 | 1.00 |
| ▸ | HTR7 | P34969 | 3/20 | 1.00 |
| ▸ | HTR2B | P41595 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | HTR5A | P47898 | 2/20 | 1.00 |
| ▸ | HTR6 | P50406 | 2/20 | 1.00 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 1.00 |
| ▸ | HTR3B | O95264 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | HTR1E | P28566 | 1/20 | 1.00 |
| ▸ | HTR1F | P30939 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serotonin SCHEMBL30057954 | 1.00 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL1495 | 1.00 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL29349412 | 1.00 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL8208967 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL29781387 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL25341783 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL29669289 | 0.98 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL396997 | 0.98 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL3091827 | 0.98 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL1675866 | 0.98 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118234708-A | Formulations of nudity alkali analogs and methods of use | 赛本爱尔兰有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118064317-A | Lactobacillus paracasei for improving cathartic colon and application thereof | 江南大学 | 2024-05-24 | — | — | CN | claimed |
| CN-117915901-A | Combined administration method of deutetrabenazine and CYP2D6 inhibitor | 纽罗克里生物科学有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117479938-A | Methods of administering certain VMAT2 inhibitors | 纽罗克里生物科学有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117177959-A | Nudity analogs, salts, compositions, and methods of use | 赛本爱尔兰有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-117143766-A | Lactobacillus paracasei for repairing enteric nerves and application thereof | 江南大学 | 2023-12-01 | — | — | CN | claimed |
| CN-117024397-A | Amphetamine derivatives, preparation method and application thereof | 江苏恩华药业股份有限公司 | 2023-11-10 | — | — | CN | claimed |
| WO-2023178111-A2 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2023-09-21 | — | — | WO | claimed |
| CN-116438169-A | Serotonin receptor modulators | 东北大学 | 2023-07-14 | — | — | CN | claimed |
| WO-2023133573-A1 | METHODS AND SYSTEMS FOR TREATING CHRONIC PAIN CONDITIONS USING DIGITAL THERAPEUTICS IN COMBINATION WITH OTHER THERAPIES | Mahana Therapeutics, Inc. (US) | 2023-07-13 | — | — | WO | claimed |
| CN-1653025-A | NK1Antagonists | SCHERING CORP (US) | 2005-08-10 | — | — | CN | claimed |
| CN-1585748-A | NK1 antagonists | SCHERING CORP (US) | 2005-02-23 | — | — | CN | claimed |
| CN-1315830-A | Method for treating anxiety disorders | LILLY CO ELI (US) | 2001-10-03 | — | — | CN | claimed |
| CN-1312802-A | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents | AMERICAN HOME PROD (US) | 2001-09-12 | — | — | CN | claimed |
| US-6060642-A | TRANSGENIC MICE MODELS FOR GENE FUNCTION, WHEREIN THE TRANSGENIC MICE ARE CHARACTERIZED BY HAVING ALTERED SEROTONIN 5-HT6 RECEPTOR GENE FUNCTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-05-09 | — | — | US | claimed |
| WO-2000006082-A2 | TREATMENT OF ANXIETY DISORDERS | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | claimed |
| EP-0835107-A1 | THE USE OF ALPHA-1C-SELECTIVE ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF URINARY INCONTINENCE | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1998-04-15 | — | — | EP | claimed |
| EP-0751790-A4 | SEROTONIN (5-HT 1A) RECEPTOR LIGANDS AND IMAGING AGENTS | UNIV PENNSYLVANIA (US) | 1997-06-11 | — | — | EP | claimed |
| EP-0751790-A1 | SEROTONIN (5-HT 1A) RECEPTOR LIGANDS AND IMAGING AGENTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1997-01-08 | — | — | EP | claimed |
| WO-1996038143-A1 | THE USE OF ALPHA-1C-SELECTIVE ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF URINARY INCONTINENCE | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1996-12-05 | — | — | WO | claimed |